Literature DB >> 14609191

Diagnostic value of routine clinical parameters in acute myocardial infarction: a comparison to delayed contrast enhanced magnetic resonance imaging.

C Klein, E Nagel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14609191     DOI： 10.1023/a:1025863521161

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN： 1569-5794            Impact factor:   2.357


× No keyword cloud information.
  10 in total

1.  Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomography.

Authors:  Christoph Klein; Stephan G Nekolla; Frank M Bengel; Mitsuru Momose; Andrea Sammer; Felix Haas; Bernhard Schnackenburg; Wolfram Delius; Harald Mudra; Dieter Wolfram; Markus Schwaiger
Journal:  Circulation       Date:  2002-01-15       Impact factor: 29.690

2.  The determination of myocardial viability using Gd-DTPA in a canine model of acute myocardial ischemia and reperfusion.

Authors:  R S Pereira; F S Prato; G Wisenberg; J Sykes
Journal:  Magn Reson Med       Date:  1996-11       Impact factor: 4.668

3.  Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase-MB elevation.

Authors:  M J Ricciardi; E Wu; C J Davidson; K M Choi; F J Klocke; R O Bonow; R M Judd; R J Kim
Journal:  Circulation       Date:  2001-06-12       Impact factor: 29.690

4.  Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction.

Authors:  E Wu; R M Judd; J D Vargas; F J Klocke; R O Bonow; R J Kim
Journal:  Lancet       Date:  2001-01-06       Impact factor: 79.321

5.  Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function.

Authors:  R J Kim; D S Fieno; T B Parrish; K Harris; E L Chen; O Simonetti; J Bundy; J P Finn; F J Klocke; R M Judd
Journal:  Circulation       Date:  1999-11-09       Impact factor: 29.690

6.  Myocardial viability in chronic ischemic heart disease: comparison of contrast-enhanced magnetic resonance imaging with (18)F-fluorodeoxyglucose positron emission tomography.

Authors:  Harald P Kühl; Aernout M Beek; Arno P van der Weerdt; Mark B M Hofman; Cees A Visser; Adriaan A Lammertsma; Nicole Heussen; Frans C Visser; Albert C van Rossum
Journal:  J Am Coll Cardiol       Date:  2003-04-16       Impact factor: 24.094

7.  Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function.

Authors:  K M Choi; R J Kim; G Gubernikoff; J D Vargas; M Parker; R M Judd
Journal:  Circulation       Date:  2001-09-04       Impact factor: 29.690

8.  The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction.

Authors:  R J Kim; E Wu; A Rafael; E L Chen; M A Parker; O Simonetti; F J Klocke; R O Bonow; R M Judd
Journal:  N Engl J Med       Date:  2000-11-16       Impact factor: 91.245

9.  Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study.

Authors:  Anja Wagner; Heiko Mahrholdt; Thomas A Holly; Michael D Elliott; Matthias Regenfus; Michele Parker; Francis J Klocke; Robert O Bonow; Raymond J Kim; Robert M Judd
Journal:  Lancet       Date:  2003-02-01       Impact factor: 79.321

10.  Contrast magnetic resonance imaging in the assessment of myocardial viability in patients with stable coronary artery disease and left ventricular dysfunction.

Authors:  K Ramani; R M Judd; T A Holly; T B Parrish; V H Rigolin; M A Parker; C Callahan; S W Fitzgerald; R O Bonow; F J Klocke
Journal:  Circulation       Date:  1998-12-15       Impact factor: 29.690
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.